Hemazide Injection
Marketer
Cadila Pharmaceuticals Ltd
Salt Composition
Azacitidine (100mg)
Overview Hemazide Injection
Myeloid-targeting injection, Hemocyte, treats various blood cancers, notably all Myelodysplastic Syndrome (MDS) subtypes in adults. Its application may extend to other conditions as directed by a physician. Administered intravenously under strict medical oversight, dosage and frequency are individually determined, varying with the specific condition and potentially adjusted over time. Adherence to the prescribed regimen is crucial; improper usage or overdose risks severe adverse reactions. Therapeutic benefits might not be immediately apparent, potentially requiring weeks or months; discontinuation should only occur under medical guidance. Common side effects encompass injection site inflammation (pain, swelling, redness), nausea, vomiting, and fatigue. Report any concerning symptoms promptly; management strategies may be available. Vaccinations during treatment necessitate prior physician consultation. Regular blood work monitoring, including liver, kidney, and cardiac function, is mandatory. Prior to commencing treatment, disclose any pre-existing liver or kidney ailments, and all current medications, including anti-infectives, as drug interactions are possible. Hemocyte is contraindicated during pregnancy and lactation.
Uses of Hemazide Injection
Myelodysplastic syndrome: Hematological malignancy therapies
Major Benefits of Hemazide Injection:
Administering this medication will be handled by your physician or their registered nurse. Self-medication is strongly discouraged.
Common Side effects of Hemazide Injection:
- Injection site reactions (pain, swelling, redness)
- Vomiting
- Weakness
- Nausea
- Decreased potassium level in blood
- Bruise
- Fever
- Chills
- Diarrhea
- Constipation
How to use Hemazide Injection:
This medication will be administered by your healthcare provider; please do not attempt self-medication.
How Hemazide Injection works:
Leukaemia treatment with Hemazide Injection involves disrupting the DNA and RNA of cancerous cells, thereby halting their proliferation. This anticancer agent facilitates the healthy development of new blood cells within the bone marrow.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Hemazide Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Hemazide Injection during pregnancy is contraindicated due to established fetal risk. In exceptional, life-threatening circumstances, a physician might consider its use if the potential benefits outweigh the known hazards. Physician consultation is advised.
Breast feedingUNSAFE
Administration of Hemazide Injection is contraindicated while breastfeeding due to potential infant toxicity. Studies indicate a risk of harmful effects to the nursing infant.
DrivingUNSAFE
Hemazide Injection may induce adverse reactions, potentially impairing driving ability. Fatigue is one such possible side effect that could compromise safe driving.
KidneyCAUTION
Patients with kidney impairment should receive Hemazide Injection only with careful monitoring. The Hemazide Injection dosage may require modification. Physician consultation is advised.
LiverCAUTION
Individuals with hepatic impairment should receive Hemazide Injection with close monitoring; dosage modification may be necessary. Physician consultation is advised. Hemazide Injection is contraindicated in patients exhibiting advanced hepatocellular carcinoma.
What if you forget to take Hemazide Injection :
NA
Facts to Know About Hemazide Injection
| Label | Value |
|---|---|
| Chemical Type | Pyrimidine Nucleoside Analog |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Action Category | Metabolic inhibitors |
3,018 People bought this recently